title: Chlamydia trachomatis reactive T lymphocytes from upper genital tract tissue specimens.
abstract: Chlamydia trachomatis infection is associated with pelvic inflammatory disease (PID) and tubal factor infertility (TFI). We investigated the role of C. trachomatis as a target antigen of endometrial and salpingeal tissue lymphocytes derived from PID and TFI patients. Antigen specificity of the tissue originated T lymphocyte lines (TLL) was tested against C. trachomatis elementary bodies and chlamydial heat shock protein 60 (CHSP60). C. trachomatis antigen stimulated proliferation in two out of eight endometrial TLL derived from PID patients and three out of four TLL derived from TFI patients. All (n = 4) TLL derived from the salpingeal specimens responded to CHSP60 compared with only one out of 12 TLL derived from the endometrial specimens. In-vivo expression of interferon-gamma (IFN-gamma) mRNA revealed that it was present in nine of 13 specimens obtained from PID patients. The dominant activity of type-1 T lymphocytes was confirmed by the in-vitro production of IFN-gamma (median 1007 pg/ml) from all (n = 5) C. trachomatis specific TLL while IL-5 secretion was lower (median 779 pg/ml). In conclusion, C. trachomatis reactive TLL were established from in-vivo activated lymphocytes from the upper genital tract tissue of PID and TFI patients. The reactivity of the salpingeal TLL to CHSP60 provided further evidence that immunoreactivity to CHSP60 is a predominant response in patients with tubal damage.
authors.affiliation: National Public Health Institute, Aapistie 1, Box 310, 90101 Oulu, Finland.
authors.forename: A
authors.initials: A
authors.lastname: Kinnunen
authors.forename: P
authors.initials: P
authors.lastname: Molander
authors.forename: A
authors.initials: A
authors.lastname: Laurila
authors.forename: I
authors.initials: I
authors.lastname: Rantala
authors.forename: R
authors.initials: R
authors.lastname: Morrison
authors.forename: M
authors.initials: M
authors.lastname: Lehtinen
authors.forename: R
authors.initials: R
authors.lastname: Karttunen
authors.forename: A
authors.initials: A
authors.lastname: Tiitinen
authors.forename: J
authors.initials: J
authors.lastname: Paavonen
authors.forename: H M
authors.initials: HM
authors.lastname: Surcel
mesh_terms: D000293:Adolescent; D000328:Adult; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line / Q000378:metabolism; D018834:Chaperonin 60 / Q000276:immunology; D002692:Chlamydia trachomatis / Q000276:immunology* / Q000378:metabolism; D016207:Cytokines / Q000378:metabolism; D005260:Female; D005836:Genitalia, Female / Q000276:immunology* / Q000473:pathology; D006801:Humans; D007247:Infertility, Female / Q000276:immunology* / Q000378:metabolism / Q000473:pathology; D007378:Interleukins / Q000494:pharmacology; D008875:Middle Aged; D000292:Pelvic Inflammatory Disease / Q000276:immunology* / Q000378:metabolism / Q000473:pathology; D013601:T-Lymphocytes / Q000276:immunology* / Q000473:pathology
chemical_list: D018834:Chaperonin 60; D016207:Cytokines; D007378:Interleukins